However, at higher antibody concentrations, the anti-tumoural potency of MOv18 IgE was unaltered, suggesting that the number of antigen-binding sites on the antibody outweighed any blocking effects of free FRα antigen and were thus sufficient to trigger cancer cell cytotoxicity. Here, FOLR1 is linked to cancer.